Organisational principles of existing colorectal cancer screening programmes in the world medical practice: literature review and analysis of approaches to evidence based screening model for Ukraine

Authors

DOI:

https://doi.org/10.32782/2077-6594/2023.4/17

Keywords:

healthcare organisation, screening, malignant neoplasms, colorectal cancer, model, early diagnosis, prevention, public awareness, public health

Abstract

Introduction. The incidence of colorectal cancer (CRC) is increasing worldwide, making it the third most common cancer affecting men and the second most common in women. The mortality rate from CRC increases depending on the stage of the disease, while the 5-year survival rate at stage IV is significantly decreased. Screening can detect colorectal cancer at an early stage of the disease, but it can also prevent the development of the disease by identifying polyps that can be removed before they become malignant. Another proof of the potential benefits of CRC screening is the high prevalence of this pathology among the population, its long preclinical and pre-cancerous periods, and the affordability of treatment. Countries with screening programmes have lower CRC mortality rates than countries without them, which confirms the effectiveness and importance of implementing such a programme, due to the medical and social significance of this pathology. Purpose is to substantiate the necessity of developing a colorectal cancer screening programme in Ukraine. Materials and methods. Using the bibliosemantic method, a number of foreign and national sources of information on the main stages of cancer screening were analysed, including current developments concerning the implementation of colorectal cancer screening. The data from the National Cancer Registry of Ukraine and official statistics of the State Statistics Service of Ukraine on deaths and population were used to substantiate the national screening programme. Results. The organisational principles of colorectal cancer screening programmes worldwide were analysed. The practical significance and economic efficiency of implementing a programme focused on the prevention and early detection of the disease at the national level were considered. Ways to preserve the quality and duration of life, human and financial resources using screening, as well as potential opportunities to reduce public spendings were presented. Population-based screening programme requires an appropriate informational and technical infrastructure, including the development of an invitation, reminder and tracking system for screening results, follow-up and monitoring of clinical outcomes. Conclusions. The implementation of the colorectal cancer screening system in Ukraine should take into account the current initial resources and the condition of the healthcare system, based on the principles of organised, staged population-based screening.

References

Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021: 71: 209–249. https://doi.org/10.3322/caac.21660World Health Organization. Global health estimates 2020: deaths by cause, age, sex, by country and by region, 2000–2019.

Global Burden of Disease Cancer, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol.2017;3(4):524–48.

Jakovljevic M, Zugic A, Rankovic A, Dagovic A. Radiation therapy remains the key cost driver of oncology inpatient treatment. J Med Econ. 2015 Jan;18(1):29–36. doi: 10.3111/13696998.2014.971162. Epub 2014 Oct 10. PMID: 25268728.

Jakovljevic M, Gutzwiller F, Schwenkglenks M, Milovanovic O, Rancic N, Varjacic M, Stojadinovic D, Dagovic A, Matter-Walstra K. Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma. J BUON. 2014 Oct-Dec;19(4):1111–20. PMID: 25536624.

Kuntz KM, Lansdorp-Vogelaar I, Rutter CM, Knudsen AB, van Ballegooijen M, Savarino JE, Feuer EJ, Zauber AG. A systematic comparison of microsimulation models of colorectal cancer: the role of assumptions about adenoma progression. Med Decis Making. 2011 Jul-Aug;31(4):530–9. doi: 10.1177/0272989X11408730. Epub 2011 Jun 14. PMID: 21673186; PMCID: PMC3424513.

Brenner H, Hoffmeister M, Stegmaier C, Brenner G, Altenhofen L, Haug U. Risk of progression of advanced adenomas to colorectal cancer by age and sex: estimates based on 840,149 screening colonoscopies. Gut. 2007 Nov;56(11):1585–9. doi:10.1136/gut.2007.122739. Epub 2007 Jun 25. PMID: 17591622; PMCID:PMC2095643.

Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019. JAMA Oncology. 2021 Dec 30;8(3).

Федоренко ЗП, Гулак ЛО, Михайлович ЮЙ та ін. Рак в Україні, 2021–2022. Захворюваність, смертність, показники діяльності онкологічної служби. Бюлетень Національного канцер-реєстру України. № 24. URL: http://www.ncru.inf.ua/publications/BULL_24/index.htm (date of access: 16.09.2023).

Cancer control: Early detection. WHO guide for effective programmes. – Geneva : World Health Organization, 2007. 50 p.

Malila N, Senore C, Armaroli P; International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Organisation. Endoscopy. 2012 Sep;44 Suppl 3:SE31-48. doi: 10.1055/s-0032-1309783. Epub 2012 Sep 25. PMID: 23012121.

Любінець ОВ, Гржибовський ЯЛ. Медико-соціальні детермінанти здоров’я (огляд світової літератури). Український медичний часопис 2020;136(2). https://doi.org/10.32471/umj.1680-3051.136.175646

Winawer S, Claseen M, Lambert R, et al. World Gastroenterology Organisation. International Digestive Cancer Alliance Practice Guidelienes: Colorectal cancer screening. WGO, Milwaukee, 2008. 18 p.

Davidson KW, Barry MJ, Mangione CM, et al.; US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. Published online May 18, 2021. doi:10.1001/jama.2021.6238

Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. Published online May 18, 2021. doi:10.1001/jama.2021.4417

Knudsen AB, Rutter CM, Peterse EFP, et al. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. Published online May 18, 2021. doi:10.1001/jama.2021.5746

Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3): 145–164. doi:10.3322/caac.21601 [PubMed: 32133645]

Ladabaum U, Mannalithara A, Meester RGS, Gupta S, Schoen RE. Cost-effectiveness and national effects of initiating colorectal cancer screening for average-risk persons at age 45 years instead of 50 years. Gastroenterology. 2019;157(1):137–148. doi:10.1053/j.gastro.2019.03.023 [PubMed: 30930021]

Siegel RL, Jakubowski CD, Fedewa SA, et al.; Colorectal cancer in the young: epidemiology, prevention, management. Am Soc Clin Oncol Educ Book. 2020;40:1–14.

Malila N, Oivanen T, Malminiemi O, et al. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. BMJ. 2008;337:a2261.

Heresbach D, Manfredi S, D'halluin PN, et al. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test. Eur J Gastroenterol Hepatol. 2006;18:427–433.

Burch JA, Soares-Weiser K, St John DJ, et al. Diagnostic accuracy of faecal occult blood tests used in screening for colorectal cancer: a systematic review. J Med Screen. 2007;14:132–137.

Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008;103:1541–1549.

Rabeneck L, Rumble RB, Thompson F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening. Can J Gastroenterol. 2012;26:131–147.

Bretagne JF, Piette C, Cosson M, Durand G, Lièvre A. Switching from guaiac to immunochemical faecal occult blood test increases participation and diagnostic yield of colorectal cancer screening. Dig Liver Dis. 2019 Oct;51(10):1461–1469. doi: 10.1016/j.dld.2019.05.004. Epub 2019 May 29. PMID: 31151896.

Семенюк ОА, Гржибовський ЯЛ. Характеристика концептуальної моделі попередження втрати населення працездатного віку на регіональному рівні. Вісник соціальної гігієни та організації охорони здоров’я [інтернет]. 26, Червень 2015 [cited 15, Листопад 2023];(1). Available at: https://ojs.tdmu.edu.ua/index.php/visnyk-gigieny/article/view/4686

Wieszczy P, Kaminski MF, Franczyk R, Loberg M, Kobiela J, Rupinska M, Kocot B, Rupinski M, Holme O, Wojciechowska U, Didkowska J, Ransohoff D, Bretthauer M, Kalager M, Regula J. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies. Gastroenterology. 2020 Mar;158(4):875–883.e5. doi: 10.1053/j.gastro.2019.09.011. Epub 2019 Sep 26. PMID: 31563625.

He X, Hang D, Wu K, Nayor J, Drew DA, Giovannucci EL, Ogino S, Chan AT, Song M. Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps. Gastroenterology. 2020 Mar;158(4):852–861.e4. doi: 10.1053/j.gastro.2019.06.039. Epub 2019 Jul 11. PMID: 31302144; PMCID: PMC6954345.

Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: An update. World J Gastroenterol. 2017 May 28;23(20):3632–3642. doi: 10.3748/wjg.v23.i20.3632. PMID: 28611516; PMCID: PMC5449420.

Burr NE, Plumb A, Sood R, Rembacken B, Tolan DJM. CT colonography remains an important test for colorectal cancer. Gut. 2022 Jan;71(1):217-218. doi: 10.1136/gutjnl-2021–324399. Epub 2021 Mar 22. PMID: 33753420.

Sha J, Chen J, Lv X, Liu S, Chen R, Zhang Z. Computed tomography colonography versus colonoscopy for detection of colorectal cancer: a diagnostic performance study. BMC Med Imaging. 2020 May 18;20(1):51. doi: 10.1186/s12880-020-00446-7. PMID: 32423413; PMCID: PMC7236500.

Yasuda T, Honda T, Utano K, Kato T, Togashi K, Yamaguchi S, Yasaka T. Diagnostic accuracy of ultra-low-dose CT colonography for the detection of colorectal polyps: a feasibility study. Jpn J Radiol. 2022 Aug;40(8):831–839. doi: 10.1007/s11604-022-01266-1. Epub 2022 Mar 28. PMID: 35344130.

Mendivil J, Appierto M, Aceituno S, Comas M, Rué M. Economic evaluations of screening strategies for the early detection of colorectal cancer in the average-risk population: A systematic literature review. PLoS One. 2019 Dec 31;14(12):e0227251. doi: 10.1371/journal.pone.0227251. PMID: 31891647; PMCID: PMC6938313.

Melnitchouk N, Soeteman DI, Davids JS, Fields A, Cohen J, Noubary F, Lukashenko A, Kolesnik OO, Freund KM. Cost-effectiveness of colorectal cancer screening in Ukraine. Cost Eff Resour Alloc. 2018 Jun 7;16:20. doi: 10.1186/s12962-018-0104-0. PMID: 29977160; PMCID: PMC5992826.

Wang J, de Jonge L, Cenin DR, Li P, Tao S, Yang C, Yan B, Lansdorp-Vogelaar I. Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study. Prev Med Rep. 2022 Jul 4;29:101891. doi: 10.1016/j.pmedr.2022.101891.PMID: 35864929; PMCID: PMC9294625.

Рингач НО, Керецман АО, Рогач ІМ. Скринінг колоректального раку: світовий досвід та підходи до обґрунтування регіональної програми в Закарпатській області. Україна. Здоров’я нації. 2017. № 3(44). С. 196–202.

Europe's Beating Cancer Plan 2021.

European Commission Guidelines For Quality Assurance in Colorectal Cancer Screening and Diagnosis, 2020.

Digestive Cancers Europe: White Paper on Colorectal Cancer Screening in Europe, 2019.

Digestive Cancers Europe: Roadmap for Colorectal Cancer Screening in Europe, 2019.

Trebenda E, Cipora E, Sygit K, Gąska I. Demographic and social chosen health behaviours among people over 55 years of age in the field of chronic disease prevention on the example of colorectal cancer. Pielęgniarstwo w Opiece Długoterminowej / Long-Term Care Nursing 2021;6(1):35–50.

Гржибовський ЯЛ. Глобальні та структурні детермінанти впливу на здоров’я населення (за результатами опитування організаторів охорони здоров’я України). Україна. Здоров'я нації. 2018, 4(1): 77–83.

Institut National du Cancer, February 2018.

Published

2023-12-18

Issue

Section

Organization and management of health care